Clinical Drug-Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor Alectinib.

Autor: Morcos, Peter N.1 peter.morcos@roche.com, Cleary, Yumi2, Guerini, Elena2, Dall, Georgina3, Bogman, Katrijn2, Petris, Luigi4, Viteri, Santiago5, Bordogna, Walter2, Yu, Li1, Martin‐Facklam, Meret2, Phipps, Alex6
Zdroj: Clinical Pharmacology in Drug Development. May/Jun2017, Vol. 6 Issue 3, p280-291. 12p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje